Incorporating some potential obstacles arising from recent Chinese developments
15/09/23 -"Despite Philips gaining confidence, thanks to promising testing results for respiratory devices, improving operations and a big new investor coming on board, our target price resets lower due to ..."
Pages
69
Language
English
Published on
15/09/23
You may also be interested by these reports :
30/07/26
Dräger’s final Q2 26 results confirmed the preliminary figures released on 13 July. Margins accelerated in both divisions, alongside a meaningful ...
29/07/26
bioMerieux’s H1 profitability largely met expectations. Q2 sales growth was driven by increases across both segments, supported by its GO28 growth ...
28/07/26
Philips’ Q2 sales surpassed expectations, with profitability excluding one-offs meeting forecasts. The 2026 guidance was reaffirmed. However, ...
24/07/26
Sartorius reported mixed Q2 26 numbers, with revenue below consensus (-2.3%) but underlying EBITDA slightly ahead (+0.5%). Equipment inflected as ...